Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Short Interest Update

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) was the recipient of a large decline in short interest in May. As of May 29th, there was short interest totaling 225,427 shares, a decline of 45.5% from the May 14th total of 413,714 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 760,388 shares, the short-interest ratio is currently 0.3 days.

Analysts Set New Price Targets

A number of research analysts have recently commented on CLPBY shares. Kepler Capital Markets upgraded shares of Coloplast A/S to a “strong-buy” rating in a research report on Wednesday, May 20th. The Goldman Sachs Group lowered shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 7th. One analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Coloplast A/S has an average rating of “Hold”.

Coloplast A/S Stock Up 1.4%

Shares of OTCMKTS:CLPBY opened at $5.99 on Friday. Coloplast A/S has a 52-week low of $5.83 and a 52-week high of $10.03. The firm has a fifty day moving average of $6.38 and a 200 day moving average of $7.49. The firm has a market capitalization of $13.50 billion, a PE ratio of 42.79, a price-to-earnings-growth ratio of 1.90 and a beta of 0.18. The company has a debt-to-equity ratio of 1.50, a quick ratio of 0.81 and a current ratio of 1.30.

Coloplast A/S (OTCMKTS:CLPBY) last announced its earnings results on Tuesday, May 12th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.01. Coloplast A/S had a net margin of 7.46% and a return on equity of 31.96%. The company had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.11 billion. As a group, research analysts anticipate that Coloplast A/S will post 0.4 EPS for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.